Synthesis of both the enantiomers of aseanostatin P5 (sarcinic acid), an inhibitor of myeloperoxidase release, and four diastereomers of aggreceride A, a platelet aggregation inhibitor.
T Kitahara, S Aono, K Mori
Index: Biosci. Biotechnol. Biochem. 59(1) , 78-82, (1995)
Full Text: HTML
Abstract
Both the enantiomers of aseanostatin P5 (sarcinic acid), an inhibitor of myeloperoxidase (MPO) release from human polymorphonuclear leukocytes (PMN), with high optical purity were synthesized by starting from (S)-2-methylbutanol and methyl (S)-3-hydroxy-2-methylpropanoate. They were converted to four diastereomers of aggreceride A, a platelet aggregation inhibitor.
Related Compounds
Related Articles:
2004-05-01
[Appl. Microbiol. Biotechnol. 64(4) , 497-504, (2004)]
Antibacterial compounds from Siraitia grosvenorii leaves.
2011-05-01
[Nat. Prod. Res. 25 , 890-897, (2011)]
1991-05-01
[J. Antibiot. 44(5) , 524-32, (1991)]
Impact on lipid membrane organization by free branched-chain fatty acids.
2006-11-07
[Phys. Chem. Chem. Phys. 8(41) , 4792-7, (2006)]
Enantioselective determination of anteiso fatty acids in food samples.
2007-06-15
[Anal. Chem. 79(12) , 4696-701, (2007)]